Schrodinger (NASDAQ:SDGR) 株価情報

Schrodinger

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Schrodinger Inc

Press Releases

Schrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis

Schrödinger Reports Third Quarter 2024 Financial Results

Schrödinger Broadens and Accelerates Predictive Toxicology Initiative

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference

Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities

Schrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26

SDGR

Firefly Neuroscience, Inc. - Common Stock

Firefly Neuroscience

American Well Corporation Class A Common Stock

American Well

CareCloud

Certara

Definitive Healthcare Corp. - Class A Common Stock

Definitive Healthcare

Doximity

Evolent Health

Forian

GoodRx Holdings, Inc. - Class A Common Stock

GoodRx Holdings

Health Catalyst

HealthStream

icad

LifeMD

MultiPlan Corporation Class A Common Stock

MultiPlan

OneMedNet

OptimizeRx

Phreesia

Pheton Holdings Ltd - Class A Ordinary Shares

Pheton Holdings

Simulations Plus

Sophia Genetics

TruBridge

Teladoc Health

Veeva Systems

VSee Health

Waystar Holding

Keybanc

BMO Capital

Morgan Stanley

Leerink Partners

Citigroup

Comments

Schrodinger

ニュース

パートナーシップ

ベンジンガ・グローバル